Latest stories on ANIP
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
Business Insider50 · neutralgeneral
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target? - qz.com
Quartz64 · neutralanalyst
ANIP's Cortrophin Gel Surge Powers 2026 Growth Outlook - qz.com
Quartz73 · bullishproduct/pr
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter | ANIP Stock News
StockTitan48 · neutralgeneral
ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run
The Motley Fool42 · neutralgeneral
ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge
The Motley Fool42 · neutralgeneral
ANI Pharmaceuticals: Rare Disease Growth At A Generics Multiple
Seeking Alpha63 · neutralanalyst
ANI Pharmaceuticals Signals Confident 2026 Growth Path
TipRanks63 · neutralearnings
Ani (ANIP) Q1 2026 Earnings Call Transcript
Yahoo Finance50 · neutralearnings
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference | ANIP Stock News
StockTitan56 · neutralgeneral
ANI Pharmaceuticals, Inc. (ANIP): A Small Cap Value Stock Capitalizing on Generic Drugs Opportunities
Yahoo Top67 · bullishproduct/pr